Role of B cell stimulatory factor 1/interleukin 4 in clonal proliferation of B cells
- PMID: 3500217
Role of B cell stimulatory factor 1/interleukin 4 in clonal proliferation of B cells
Abstract
B cell stimulatory factor 1 (BSF-1)/interleukin 4 (IL-4) has striking effects on colony formation in soft agar by small resting B lymphocytes. BSF-1 alone induces colony formation in this cell population, presumably in costimulation with a mitogenic substance present in bacto-agar. In costimulation with anti-IgM antibodies, BSF-1 caused initial proliferation of 8 to 10% of B cells, resulting in a large number of cell clusters (10 to 40 cells/clone) after 3 to 4 days of incubation. However, substantial number of colonies (greater than 40 cells/clone) developed only from these clusters when IL-1 was added to the cultures. Using a modified immunoperoxidase staining technique for the determination of IgM allotype, evidence was obtained that B cell colonies stimulated with BSF-1 are derived from a single progenitor cell. Neutralization of BSF-1 with 11B11 after a culture period of 1 to 4 days inhibits further proliferation of B cell colonies, indicating that the action of BSF-1 extends for several cell generations beyond initial stimulation from the resting state. Furthermore, it is demonstrated that the synergistic action of IL-1 with BSF-1 is confined to the late culture period, indicating a growth-promoting effect by IL-1 for activated B cells.
Similar articles
-
The requirement for high intracellular cyclic adenosine monophosphate concentrations distinguishes two pathways of B cell activation induced with lymphokines and antibody to immunoglobulin.J Immunol. 1988 Jan 15;140(2):580-2. J Immunol. 1988. PMID: 2826594
-
Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.Eur J Immunol. 1989 May;19(5):913-21. doi: 10.1002/eji.1830190519. Eur J Immunol. 1989. PMID: 2525477
-
Detection and characterization of a B cell stimulatory factor (BSF-TC) derived from a bone marrow stromal cell line.J Immunol. 1989 Jun 1;142(11):3894-900. J Immunol. 1989. PMID: 2785568
-
Induction of antigen-specific proliferation in affinity-purified small B lymphocytes: requirement for BSF-1 by type 2 but not type 1 thymus-independent antigens.J Immunol. 1986 Mar 15;136(6):2080-9. J Immunol. 1986. PMID: 3081637
-
Early events in lymphopoiesis: the role of interleukins 1 and 7.J Autoimmun. 1989 Jun;2 Suppl:155-61. doi: 10.1016/0896-8411(89)90126-1. J Autoimmun. 1989. PMID: 2673269 Review.
Cited by
-
Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.Infect Immun. 2007 Feb;75(2):621-33. doi: 10.1128/IAI.01009-06. Epub 2006 Nov 21. Infect Immun. 2007. PMID: 17118982 Free PMC article.
-
Maintenance of growth transformation with Epstein-Barr virus is mediated by secretion of autocrine growth factors in two serum-free B-cell lines.J Virol. 1988 Sep;62(9):3415-21. doi: 10.1128/JVI.62.9.3415-3421.1988. J Virol. 1988. PMID: 2841494 Free PMC article.
-
Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities.Infect Immun. 2005 Mar;73(3):1330-42. doi: 10.1128/IAI.73.3.1330-1342.2005. Infect Immun. 2005. PMID: 15731030 Free PMC article.
-
Suppressive activity of interleukin 4 on the induction of antigen-specific cytotoxic T cells in humans.Jpn J Cancer Res. 1991 May;82(5):585-92. doi: 10.1111/j.1349-7006.1991.tb01890.x. Jpn J Cancer Res. 1991. PMID: 1712006 Free PMC article.